|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| (11) | Number of the document | 2714733 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12790075.1 |
| Date of filing the European patent application | 2012-05-16 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-23 |
| (46) | Date of publication of the claims translation | 2019-06-10 |
| (86) | Number | PCT/US2012/038219 |
| Date | 2012-05-16 |
| (87) | Number | WO 2012/162067 |
| Date | 2012-11-29 |
| (30) | Number | Date | Country code |
| 201161488716 P | 2011-05-21 | US | |
| 201161530353 P | 2011-09-01 | US |
| (72) |
HUANG, Ling, US
JOHNSON, Leslie, S., US
|
| (73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | CD3 surišančios molekulės, galinčios jungtis prie žmogaus ir ne žmogaus CD3 |
| CD3-BINDING MOLECULES CAPABLE OF BINDING TO HUMAN AND NON-HUMAN CD3 |
| Payment date | Validity (years) | Amount | |
| 2025-04-28 | 14 | 289.00 EUR |
| 2026-05-16 |